Dilated Cardiomyopathy Clinical Trials

20 recruiting

Dilated Cardiomyopathy Trials at a Glance

40 actively recruiting trials for dilated cardiomyopathy are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Houston, Columbus, and Cincinnati. Lead sponsors running dilated cardiomyopathy studies include Chinese Academy of Medical Sciences, Fuwai Hospital, Tomsk National Research Medical Center of the Russian Academy of Sciences, and Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.

Browse dilated cardiomyopathy trials by phase

Treatments under study

About Dilated Cardiomyopathy Clinical Trials

Looking for clinical trials for Dilated Cardiomyopathy? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dilated Cardiomyopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dilated Cardiomyopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 40 trials

Recruiting
Phase 2Phase 3

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Symptomatic Genetic Dilated Cardiomyopathy
Kardigan, Inc.332 enrolled33 locationsNCT07210723
Recruiting
Phase 1

A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy

Dilated Cardiomyopathy
AstraZeneca31 enrolled4 locationsNCT07241104
Recruiting
Phase 1

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM)
Rocket Pharmaceuticals Inc.8 enrolled3 locationsNCT07137338
Recruiting
Phase 2

Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

Non-ischemic Dilated Cardiomyopathy
Joshua M Hare136 enrolled4 locationsNCT04476901
Recruiting
Not Applicable

Modifying Factors in Striated Muscle Laminopathies

LaminopathiesEmery Dreifuss Muscular Dystrophy 2LMNA-Related Congenital Muscular Dystrophy+1 more
Institut National de la Santé Et de la Recherche Médicale, France40 enrolled8 locationsNCT05394506
Recruiting
Phase 1Phase 2

ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

BAG3 Mutation Associated Dilated Cardiomyopathy
Alexion Pharmaceuticals, Inc.6 enrolled7 locationsNCT07218887
Recruiting

Study of the Progression of Chronic Cardiovascular Conditions

Heart FailureHypertensionDilated Cardiomyopathy+9 more
Prolaio5,000 enrolled1 locationNCT07420907
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting

The Application of T1 Mapping in Real-World

Hypertrophic Cardiomyopathy (HCM)MyocarditisMyocardial Infarction (MI)+2 more
Chinese Academy of Medical Sciences, Fuwai Hospital2,000 enrolled1 locationNCT07354646
Recruiting

Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM)
Second Affiliated Hospital, School of Medicine, Zhejiang University330 enrolled1 locationNCT07293338
Recruiting
Not Applicable

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Heart Failure With Reduced Ejection Fraction (HFrEF)Dilated Cardiomyopathy
Ancora Heart, Inc.400 enrolled132 locationsNCT04331769
Recruiting
Phase 1

A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)

Dilated Cardiomyopathy
Emory University36 enrolled5 locationsNCT06464588
Recruiting
Not Applicable

Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients

Heart FailureNon-ischemic Dilated CardiomyopathyLeft Bundle-Branch Block+4 more
Tomsk National Research Medical Center of the Russian Academy of Sciences60 enrolled1 locationNCT05769036
Recruiting

UIC Multi-Ethnic DCM Registry

Heart FailureDilated Cardiomyopathy (DCM)
University of Illinois at Chicago1,500 enrolled1 locationNCT07145138
Recruiting
Phase 2

Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM

Dilated Cardiomyopathy
Barts & The London NHS Trust20 enrolled1 locationNCT03572660
Recruiting

Pediatric Cardiomyopathy Mutation Analysis

CardiomyopathiesHypertrophic CardiomyopathyDilated Cardiomyopathy+3 more
Indiana University300 enrolled1 locationNCT02432092
Recruiting

Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy

Heart FailureDilated CardiomyopathyLeft Bundle-Branch Block+1 more
Ashkan Eftekhari60 enrolled1 locationNCT05564689
Recruiting
Not Applicable

Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)

Dilated Cardiomyopathy (DCM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology60 enrolled1 locationNCT06922851
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+188 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1,000 enrolled1 locationNCT06741995